Nilutamide: possible utility as a second-line hormonal agent

Author： Desai A. Stadler W.M. Vogelzang N.J.

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.58, Iss.6, 2001-12, pp. : 1016-1020

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancer - a controlled study

By Smith D.C. Redman B.G. Flaherty L.E. LI L. Strawderman M. Pienta K.J.

Urology, Vol. 52, Iss. 2, 1998-08 ,pp. : 257-260

Elsevier

Access to resources Recommend Favorite

Antiandrogen withdrawal syndrome with nilutamide

By Huan S.D. Gerridzen R.G. Yau J.C. Stewart D.J.

Urology, Vol. 49, Iss. 4, 1997-04 ,pp. : 632-634

Elsevier

Access to resources Recommend Favorite

A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as second-line treatment for advanced colorectal cancer: A Japanese experience

By Ogata Yutaka

Surgery Today, Vol. 41, Iss. 1, 2011-01 ,pp. : 84-90

Springer Publishing Company

Access to resources Recommend Favorite

The utility of transthoracic echocardiography to confirm central line placement: An observational study

By Arellano Ramiro Nurmohamed Aliya Rumman Amir Day Andrew Milne Brian Phelan Rachel Tanzola Robert

Canadian Journal of Anesthesia/Journal canadien d'anesthésie, Vol. 61, Iss. 4, 2014-04 ,pp. : 340-346

Springer Publishing Company

Access to resources Recommend Favorite

Study of Placing a Second Intravenous Line in Trauma

By Merlin Mark A. Kaplan Emily Schlogl Jeffrey Suss Heather DosSantos Frank D. Ohman-Strickland Pamela Shiroff Adam

Prehospital Emergency Care, Vol. 15, Iss. 2, 2011-03 ,pp. : 208-213

Informa Healthcare

Access to resources Recommend Favorite